Skip to content
Navan

Navan

Biotech·United States·Active
Entry
–
Hold
–
Status
Active

Who owns Navan?

Navan is currently owned by Deutsche Bank Corporate Venture Capital through Deutsche Bank CVC Balance-Sheet Programme (2020 vintage). Across its history, Navan has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-08-11

Deutsche Bank Corporate Venture Capital
Most recent investor
Deutsche Bank Corporate Venture Capital
Deutsche Bank CVC Balance-Sheet Programme · 2020 · Evergreen
3 ownership periods · full history below

Key facts

HQUnited States
SectorBiotech
StatusActive

Ownership history

3 ownership periods · co-invest detected

Co-invest · 2 holders · 2019 · present
High-Tech Gruenderfonds (HTGF)
2019 · present(7yr) · HTGF III · 2017 · VC
Creandum
CreandumExited 2025
2021 · 2025(4yr) · Creandum V · 2020 · VC
IPO
MOIC
–
Deutsche Bank Corporate Venture Capital
present · Deutsche Bank CVC Balance-Sheet Programme · 2020 · Evergreen
Track Navan

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Navan?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Navan.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue